Technical writing

The Body Trade on Trial: What the US Court Record Shows

· 8 min read· AI Analytics
HealthcareConsentOrganWatchAccountabilityOpen Data

The earlier pieces in this series describe a system of gaps: bodies that can be used without consent in most states, a tissue economy that runs on free donation and paid product, and a non-transplant body trade that almost no federal law governs. None of that is theoretical. When the gaps meet bad actors, the result lands in the court record — and the court record is damning. What follows is drawn from the 13 documented cases in OrganWatch. It names companies and outcomes; individuals appear only by role.

The same crime, again and again

Read the cases together and a pattern repeats: a body or its parts are obtained under one promise — medical research, dignified handling — and used or sold for another; consent forms are forged or never sought; and what is shipped is sometimes not what was represented. In Colorado, the operators of a funeral home and its affiliated body broker were sentenced to federal prison (terms of 20 and 15 years); court records reflect that the bodies or parts of 811 people were sold, and of the authorization files examined, at least 187 were determined to be forgeries. The promise was cremation or donation; the reality was a sales catalog.

When the product is infectious

Two federal cases turn on disease. In Arizona, a jury returned a $58.5 million verdict against a Phoenix body-donation company that families said deceived them about how donated bodies would be used; a US DOT Inspector General investigation, coordinated with the FBI and CDC, found the company shipped tissue it knew to be infectious or diseased without proper hazard disclosure, and its owner was criminally convicted. In Michigan, the former president of a Detroit body-broker firm was convicted by a federal jury and sentenced to 108 months for defrauding buyers by representing remains as disease-free when some were infected with HIV and hepatitis. The market moved human tissue the way a careless supplier moves spoiled goods.

It reaches the most trusted institutions

This is not confined to fly-by-night brokers. A New Jersey tissue-recovery firm was shut down by the FDA in 2005 after its operators were charged with cutting bone and tissue from cadavers awaiting cremation and forging consent — tissue that reached thousands of transplant recipients and triggered nationwide recalls. And in December 2025, the former manager of the Harvard Medical School morgue was sentenced to 96 months in federal prison for removing parts from donated cadavers and selling them across state lines, without the knowledge of the school, the donors, or their families. The donation system's most reputable address was not immune.

The hole in the law

Why does this keep happening? Because the federal prohibition is narrow. NOTA section 301 (42 U.S.C. 274e) makes it a crime to sell a human organ for transplantation— and it is enforced: the first federal conviction for brokering kidney sales for profit came in 2011. But whole-body and non-transplant tissue donation for research and education falls largely outside it. The gap is not subtle: as part of a 2017 investigation, reporters were able to legally buy two human heads and a spinefrom a Tennessee broker for roughly $900 plus shipping. A state medical school, separately, leased unclaimed and donated bodies to a for-profit broker. Selling a kidney is a federal felony; selling a head can be a lawful transaction.

Who ends up for sale

The throughline back to the rest of this series is who the trade draws on. The bodies most easily obtained are the ones with the weakest protection — the unclaimed, the indigent, the donor families told one thing while another happened. The court record is, in effect, the enforcement layer that sits on top of the consent gap: it catches a handful of the worst actors after the fact, in a system whose default already permits use and whose federal floor barely reaches the trade at all.

What this record is

Every case here is a documented US criminal conviction, civil verdict, or federal enforcement action, each linked in OrganWatch to a Department of Justice release, court opinion, or inspector-general file. It names companies, institutions, and outcomes — never a donor, a family, or a private individual; convicted parties are referred to by role. The accountability is for the trade, documented where it has already been proven: in court.


The data: OrganWatch — the prosecutions & court-findings set, plus the testimony, money, bedside, and consent records.

The series: who buys the dead, the monopoly, the consent gap, the 50-state map, the money, and the bedside.